Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ETV1 encodes a member of the ETS (E twenty-six) family of transcription factors. Additionally we are shipping ETV1 Proteins (5) and ETV1 Kits (1) and many more products for this protein.
Showing 10 out of 71 products:
Human Polyclonal ETV1 Primary Antibody for ELISA, WB - ABIN1533755
Jeon, Davis, Braun, Sublett, Roussel, Denny, Shapiro: A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. in Oncogene 1995
Show all 3 references for ABIN1533755
Human Polyclonal ETV1 Primary Antibody for WB - ABIN610584
Feng, Tintrup, Kirsch, Nichol, Kuhse, Betz, Sanes: Dual requirement for gephyrin in glycine receptor clustering and molybdoenzyme activity. in Science (New York, N.Y.) 1998
Show all 3 references for ABIN610584
Human Monoclonal ETV1 Primary Antibody for WB - ABIN1107152
Cerveira, Ribeiro, Peixoto, Costa, Henrique, Jerónimo, Teixeira: TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. in Neoplasia (New York, N.Y.) 2006
Show all 2 references for ABIN1107152
Dog (Canine) Polyclonal ETV1 Primary Antibody for ELISA - ABIN451677
Tomlins, Rhodes, Perner, Dhanasekaran, Mehra, Sun, Varambally, Cao, Tchinda, Kuefer, Lee, Montie, Shah, Pienta, Rubin, Chinnaiyan: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. in Science (New York, N.Y.) 2005
Chicken Polyclonal ETV1 Primary Antibody for IHC, WB - ABIN2780627
Rouzier, Haudebourg, Carpentier, Valério, Amiel, Michiels, Pedeutour: Detection of the TMPRSS2-ETS fusion gene in prostate carcinomas: retrospective analysis of 55 formalin-fixed and paraffin-embedded samples with clinical data. in Cancer genetics and cytogenetics 2008
C646 treatment attenuated ETV1 protein expression and inactivated KIT-dependent pathways. Taken together, the present study suggests that CBP/p300 (show CREBBP Antibodies) may serve as novel antineoplastic targets and that use of the selective HAT (show MGEA5 Antibodies) inhibitor C646 is a promising antitumor strategy for Gastrointestinal stromal tumors.
these data reveal a JMJD2A (show KDM4A Antibodies)/ETV1/YAP1 (show YAP1 Antibodies) axis that promotes prostate cancer initiation and that may be a suitable target for therapeutic inhibition.
conclude that ETV1 is specifically expressed in the majority of gastrointestinal stromal tumors, even in some KIT-negative cases
ETV1 and COP1 (show CARD16 Antibodies) are a pair of independent predictors of prognosis for triple-negative breast cancer.
ETV1 overexpression is associated with prostate cancer aggressiveness.
Results show that ETV1 was upregulated at a higher rate in Gastrointestinal stromal tumor and was correlated with KIT expression.
These results illuminate the complex interplay of AR, ETV1, and PTEN (show PTEN Antibodies) pathways in pre-cancerous neoplasia and early tumorigenesis
YK-4-279 is a potent inhibitor of ETV1 and inhibits both the primary tumor growth and metastasis of fusion positive prostate cancer xenografts.
mutation of the KIT protein that stabilizes ETV1 is likely to be a key step by which an endogenous brain-cell progenitor may form a germinoma.
ETV1 expression is a rare event in human melanoma and seems to be rather based on hyperactivation of MAPK (show MAPK1 Antibodies) signals, by BRAF (show BRAF Antibodies) (V600E) mutation, than on ETV1 gene amplification.
we conclude that Etv1 acts downstream of FGF signaling to regulate the initiation of neurogenesis in the Xenopus retina.
this study shows that network activity dynamically modulates the properties of fast-spiking (FS) interneurons through the postmitotic expression of the transcriptional regulator Er81.
Data showed that ETV1 knockdown reduced KIT expression and GIST proliferation.
both Etv1 and Ewsr1 (show EWSR1 Antibodies) were necessary for Fgf10 (show FGF10 Antibodies) expression and elongation of the limb bud.
ETV1 appeared to support development of invasive adenocarcinoma under the background of full Pten (show PTEN Antibodies) loss
Study shows that the NR2C (show GRIN2C Antibodies) and Tiam1 (show TIAM1 Antibodies) maturation genes are synergistically controlled by the activity-dependent induction of Etv1.
The coordinate expression of Etv1 with POMC (show POMC Antibodies) cell differentiation and its interaction with the highly cell-restricted Tpit (show TBX19 Antibodies) factor indicate that Etv1 participates in a combinatorial code for pituitary cell-specific gene expression.
Etv1 orchestrates the activity-dependent gene regulation in the terminal maturation program and specifies the identity of cerebellar granule cells.
ER81 is not necessary for expression of the OB dopaminergic gene cassette and that the DA-motif is not involved in differentiation of the mammalian OB dopaminergic phenotype.
Studies indicate that Etv1 not only mediates specification of dopaminergic identity, but is also required for the proliferation and maintenance of bulbar dopaminergic neurons.
er81 embryonic expression regulation does not require FGF signalling.
This gene encodes a member of the ETS (E twenty-six) family of transcription factors. The ETS proteins regulate many target genes that modulate biological processes like cell growth, angiogenesis, migration, proliferation and differentiation. All ETS proteins contain an ETS DNA-binding domain that binds to DNA sequences containing the consensus 5'-CGGA
ets variant 1
, ets domain protein
, ets variant gene 1
, ETS translocation variant 1
, ets-related protein 81
, ets-related transcription factor XER81
, ets related protein 81
, ETS transcription factor Er81